Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01905891 · ClinicalTrials.gov registry record · NA
Nanocytology Test to Evaluate Skin Cancer in High Risk Patients
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01905891: Completed NA study, sponsored by Northwestern University.
NCT01905891 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01905891, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to correlate pathological features from specimens in order to determine if this new molecular diagnostic technique can be used to detect risk of skin cancer.
Primary Outcome
The primary outcome measure is to correlate clinical phenotype (age, skin phototype, level of photodamage, history of prior skin cancers) with morphology and nuclear characteristics, in order to determine if this new molecular diagnostic technique can be used to detect early stages of skin carcinogenesis and identify high risk-patients.
Interventions
- PROCEDURE Superficial shave biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-11 |
| Phase | NA |
What the finished NCT01905891 record still lists
NCT01905891 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Superficial shave biopsy is the first listed.
NCT01905891 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01905891 about?
NCT01905891 is a clinical study titled "Nanocytology Test to Evaluate Skin Cancer in High Risk Patients". The purpose of this study is to correlate pathological features from specimens in order to determine if this new molecular diagnostic technique can be used to detect risk of skin cancer.
What is the current status of trial NCT01905891?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2013-07. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01905891?
The interventions under investigation include: Superficial shave biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01905891?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01905891's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia